Terug
Dagbereik
€ 0,38
€ 0,40
52-Weeksbereik
€ 0,26
€ 0,40
Volume
400
50D / 200D Gem.
€ 0,38
/
€ 0,32
Vorige Slotkoers
€ 0,38
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 3,2 | 0,3 |
| P/B | 0,1 | 2,9 |
| ROE % | 3,5 | 3,7 |
| Net Margin % | 7,8 | 3,8 |
| Rev Growth 5Y % | 2,3 | 10,0 |
| D/E | 0,7 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2027 |
€ 0,27
€ 0,25 – € 0,29
|
7,8 B | 1 |
| FY2026 |
€ 0,19
€ 0,18 – € 0,20
|
7 B | 1 |
Belangrijkste Punten
Revenue grew 2,28% annually over 5 years — modest growth
Earnings declined -11,40% over the past year
ROE of 3,54% is below average
Negative free cash flow of -1,54B
P/E of 3,20 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,61%
Groei
Revenue Growth (5Y)
2,28%
Revenue (1Y)-1,33%
Earnings (1Y)-11,40%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
3,54%
ROIC3,96%
Net Margin7,79%
Op. Margin21,30%
Veiligheid
Debt / Equity
0,73
Current Ratio1,24
Interest Coverage2,30
Waardering
P/E Ratio
3,20
P/B Ratio0,11
EV/EBITDA5,34
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1,33% | Revenue Growth (3Y) | 0,66% |
| Earnings Growth (1Y) | -11,40% | Earnings Growth (3Y) | -11,67% |
| Revenue Growth (5Y) | 2,28% | Earnings Growth (5Y) | -9,60% |
| Profitability | |||
| Revenue (TTM) | 6,06B | Net Income (TTM) | 471,89M |
| ROE | 3,54% | ROA | 1,59% |
| Gross Margin | 66,72% | Operating Margin | 21,30% |
| Net Margin | 7,79% | Free Cash Flow (TTM) | -1,54B |
| ROIC | 3,96% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,73 | Current Ratio | 1,24 |
| Interest Coverage | 2,30 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 3,20 | P/B Ratio | 0,11 |
| P/S Ratio | 0,25 | PEG Ratio | -0,23 |
| EV/EBITDA | 5,34 | Dividend Yield | 0,00% |
| Market Cap | 1,51B | Enterprise Value | 6,89B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 6,06B | 6,14B | 5,98B | 5,20B | 5,54B |
| Net Income | 471,89M | 532,61M | 604,81M | -144,78M | 706,59M |
| EPS (Diluted) | 0,02 | 0,14 | 0,17 | -0,04 | 0,22 |
| Gross Profit | 4,04B | 4,20B | 4,14B | 3,40B | 3,99B |
| Operating Income | 1,29B | 1,03B | 1,21B | 386,99M | 1,42B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 29,61B | 25,49B | 24,25B | 22,58B | 20,63B |
| Total Liabilities | 13,86B | 11,96B | 13,21B | 13,47B | 12,53B |
| Shareholders' Equity | 14,15B | 12,53B | 10,18B | 8,49B | 7,89B |
| Total Debt | 10,32B | 8,42B | 9,10B | 9,49B | 9,98B |
| Cash & Equivalents | 4,94B | 3,24B | 2,32B | 2,44B | 3,87B |
| Current Assets | 13,31B | 10,70B | 10,79B | 10,40B | 9,97B |
| Current Liabilities | 10,77B | 8,14B | 9,49B | 7,33B | 7,23B |